BlackRock’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$108M Buy
25,100,374
+430,598
+2% +$2.4M ﹤0.01% 2061
2025
Q4
$221M Buy
24,669,776
+65,617
+0.3% +$406K ﹤0.01% 1614
2025
Q3
$91M Sell
24,604,159
-1,128,831
-4% -$3.08M ﹤0.01% 2158
2025
Q2
$50.2M Buy
25,732,990
+7,254,203
+39% +$15.1M ﹤0.01% 2447
2025
Q1
$32.5M Sell
18,478,787
-62,993
-0.3% -$143K ﹤0.01% 2632
2024
Q4
$49.3M Buy
18,541,780
+1,567,783
+9% +$4.04M ﹤0.01% 2462
2024
Q3
$38.9M Buy
16,973,997
+737,233
+5% +$2.25M ﹤0.01% 2633
2024
Q2
$47.4M Buy
16,236,764
+3,707,716
+30% +$11.3M ﹤0.01% 2441
2024
Q1
$45.6M Sell
12,529,048
-353,381
-3% -$679K ﹤0.01% 2487
2023
Q4
$19.5M Sell
12,882,429
-325,220
-2% -$419K ﹤0.01% 3025
2023
Q3
$17.7M Sell
13,207,649
-219,725
-2% -$366K ﹤0.01% 3004
2023
Q2
$24.2M Buy
13,427,374
+2,229,603
+20% +$3.79M ﹤0.01% 2915
2023
Q1
$18.6M Buy
11,197,771
+201,036
+2% +$407K ﹤0.01% 3015
2022
Q4
$21.1M Buy
10,996,735
+709,843
+7% +$1.44M ﹤0.01% 3011
2022
Q3
$23M Buy
10,286,892
+155,647
+2% +$444K ﹤0.01% 2957
2022
Q2
$32.8M Sell
10,131,245
-1,120,810
-10% -$4.89M ﹤0.01% 2782
2022
Q1
$59.2M Buy
11,252,055
+455,021
+4% +$2.56M ﹤0.01% 2483
2021
Q4
$91.8M Buy
10,797,034
+5,397,329
+100% +$49.6M ﹤0.01% 2266
2021
Q3
$53.7M Buy
5,399,705
+2,186,242
+68% +$19.8M ﹤0.01% 2616
2021
Q2
$29.9M Buy
3,213,463
+1,773,029
+123% +$20.2M ﹤0.01% 3055
2021
Q1
$15.1M Buy
1,440,434
+740,434
+106% +$8.28M ﹤0.01% 3342
2020
Q4
$8.19M Buy
+700,000
New +$7.28M ﹤0.01% 3474

Other funds holding NUVB